| Stephanie Jones Mcalhany, MD/PHD | |
|
201 Summit View Dr, Suite 100, Brentwood, TN 37027-4645 | |
| (800) 874-8532 | |
| Not Available |
| Full Name | Stephanie Jones Mcalhany |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology |
| Location | 201 Summit View Dr, Brentwood, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578899803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | A99144 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Jones Mcalhany, MD/PHD 201 Summit View Dr, Suite 100, Brentwood, TN 37027-4645 Ph: () - | Stephanie Jones Mcalhany, MD/PHD 201 Summit View Dr, Suite 100, Brentwood, TN 37027-4645 Ph: (800) 874-8532 |
News Archive
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.
The "Blueprint for an AIDS-free Generation," released on Thursday by U.S. Secretary of State Hillary Clinton, "shows that upfront investments to support the rapid scale-up of lifesaving AIDS treatment will yield significant savings - of both lives and dollars - in the near future," Archbishop Desmond Tutu, archbishop emeritus of Cape Town, South Africa, writes in the Huffington Post's "Impact" blog.
Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries, according to a new study by University of British Columbia and Vancouver Coastal Health Research Institute researcher Mahyar Etminan.
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
› Verified 3 days ago
Kathy Bruner, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Kenneth S Piech, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 5301 Virginia Way, Ste 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Roy W. Kirchberg Jr., M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way, Ste 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Dr. Lori D Emerson, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027 Phone: 615-695-4977 | |
Ben W Davis, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way Ste 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Randall L Woodford, MD Pathology Medicare: Medicare Enrolled Practice Location: 5301 Virginia Way, 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 | |
Dr. Soheila Yadrandji, MD Pathology Medicare: Medicare Enrolled Practice Location: 5301 Virginia Way, Suite 300, Brentwood, TN 37027 Phone: 615-221-4474 Fax: 615-234-3774 |